ANI PHARMACEUTICALS INC Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ani Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Ani Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$20.5M, a 214% decline year-over-year.
  • Ani Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $11.7M, a 72.2% decline year-over-year.
  • Ani Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was $47M.
  • Ani Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$35.3M, a 11.3% increase from 2021.
  • Ani Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$39.8M, a 148% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $47M +$82.3M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$35.3M +$4.51M +11.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$39.8M -$23.8M -148% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$16M -$32.4M -198% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $16.4M -$19M -53.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 $35.4M +$7.03M +24.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 $28.3M +$8.25M +41.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $20.1M -$12.6M -38.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $32.7M +$12.7M +63.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $20M +$19.1M +2128% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 $898K +$940K Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 -$42K Jan 1, 2012 Dec 31, 2012 10-K 2014-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.